Sterling Capital Management
NPCE icon

Sterling Capital Management’s Neuropace NPCE Stock Holding History

Sterling Capital Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12K Buy
869
+776
+834% +$11.5K ﹤0.01% 2438
2026
Q2 		$1.48K Sell
93
-63
-40% -$1.01K ﹤0.01% 3060
2026
Q1 		$2.05K Hold
156
– – ﹤0.01% 2990
2025
Q4 		$2.41K Buy
156
+98
+169% +$1.31K ﹤0.01% 3044
2025
Q3 		$598 Hold
58
– – ﹤0.01% 3142
2025
Q2 		$646 Buy
58
+44
+314% +$550 ﹤0.01% 3124
2025
Q1 		$172 Hold
14
– – ﹤0.01% 3103
2024
Q4 		$157 Hold
14
– – ﹤0.01% 3140
2024
Q3 		$98 Buy
+14
New +$102 ﹤0.01% 3192

Other funds holding NPCE

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Western Wealth Management
Western Wealth Management Golden, Colorado $3.07B AUM 19% 1-Year Est. Return
Diversified Trust
Diversified Trust Memphis, Tennessee $4.69B AUM 22.36% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sterling Capital Management's NPCE Position: Q3 2026 in Review

Sterling Capital Management increased its Neuropace (NPCE) stake by 834% in Q3 2026, buying an estimated $11.5K and bringing the position to 869 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #2438.

Sterling Capital Management first reported a position in NPCE in Q3 2024 and has held it in 9 quarters since. 29 funds tracked by Wall St. Rank hold NPCE as of Q3 2026.

  • Sterling Capital Management held 869 shares of Neuropace worth $12K as of Q3 2026.
  • Sterling Capital Management bought 776 Neuropace shares in Q3 2026, an estimated $11.5K.
  • Neuropace made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2438 holding.
  • Sterling Capital Management first reported a position in Neuropace in Q3 2024 and has held it in 9 quarters since.
  • 29 funds tracked by Wall St. Rank held Neuropace as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.